Literature DB >> 15292692

Role of endoscopic ultrasound in the diagnosis of patients with solid pancreatic masses.

Stefan Kahl1, Peter Malfertheiner.   

Abstract

Endoscopic ultrasound (EUS) is the most sensitive imaging procedure for the detection of small solid pancreatic masses and is accurate in determining vascular invasion of the portal venous system. Even compared to the new CT techniques, EUS provides excellent results in preoperative staging of solid pancreatic tumors. Compared to helical CT techniques, EUS is less accurate in detecting tumor involvement of the superior mesenteric artery. EUS staging and EUS-guided FNA can be performed in a single-step procedure, to establish the diagnosis of cancer. There is no known negative impact of tumor cell seeding due to EUS-guided fine needle aspiration (FNA). Without FNA, EUS and additional methods are not able to reliably distinguish between inflammatory and malignant masses. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15292692     DOI: 10.1159/000078732

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

Review 1.  Extramedullary Plasmacytoma of the Pancreas Complicated with Left-Sided Portal Hypertension-a Case Report and Literature Review.

Authors:  Ján Csomor; Bohuš Bunganič; Dominika Dvořáková; Petr Hříbek; Klára Kmochová; Vít Campr; Inna Tučková; Cyril Šálek; Petr Urbánek; Miroslav Zavoral
Journal:  J Gastrointest Cancer       Date:  2019-12

2.  Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples.

Authors:  Henrik Laurell; Michele Bouisson; Philippe Berthelemy; Philippe Rochaix; Sebastien Dejean; Philippe Besse; Christiane Susini; Lucien Pradayrol; Nicole Vaysse; Louis Buscail
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

3.  MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma.

Authors:  Meir Preis; Timothy B Gardner; Stuart R Gordon; J Marc Pipas; Todd A Mackenzie; Erin E Klein; Daniel S Longnecker; Edward J Gutmann; Lorenzo F Sempere; Murray Korc
Journal:  Clin Cancer Res       Date:  2011-06-07       Impact factor: 12.531

4.  Mangafodipir trisodium-enhanced MR imaging of pancreatic disease.

Authors:  Piero Boraschi; Francescamaria Donati; Roberto Gigoni; Davide Caramella; Ugo Boggi; Fabio Falaschi; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2006-01-19       Impact factor: 5.315

5.  Diagnosis of pancreatic tumors by endoscopic ultrasound-guided fine-needle aspiration.

Authors:  Jose-Celso Ardengh; Cesar-Vivian Lopes; Luiz-Felipe Pereira de Lima; Juliano-Rodrigues de Oliveira; Filadelfio Venco; Giulio-Cesare Santo; Jose-Luiz-Pimenta Modena
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

Review 6.  Pancreatic Cancer: Current Options for Diagnosis, Staging and Therapeutic Management.

Authors:  Werner Hartwig; Markus W Büchler
Journal:  Gastrointest Tumors       Date:  2013-09-12

Review 7.  Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases.

Authors:  Peter S Grimison; Melvin T Chin; Michelle L Harrison; David Goldstein
Journal:  BMC Cancer       Date:  2006-05-04       Impact factor: 4.430

8.  Low expression of tRF-Pro-CGG predicts poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Jun Li; Lei Jin; Yuan Gao; Peng Gao; Le Ma; Bei Zhu; Xu Yin; Shizhen Sui; Shuai Chen; Zijian Jiang; Chunfu Zhu
Journal:  J Clin Lab Anal       Date:  2021-03-06       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.